Association analyses based on false discovery rate implicate new loci for coronary artery disease

Nature Genetics

Volumn 49, Issue 9, 2017, Pages 1385-1391

  Nelson, Christopher P ^a,b   Goel, Anuj ^c,d   Butterworth, Adam S ^e   Kanoni, Stavroula ^f,g   Webb, Tom R ^a,b   Marouli, Eirini ^f,g   Zeng, Lingyao ^h   Ntalla, Ioanna ^f,g   Lai, Florence Y ^a,b   Hopewell, Jemma C ^c   Giannakopoulou, Olga ^f,g   Jiang, Tao ^e   Hamby, Stephen E ^a,b   Di Angelantonio, Emanuele ^e   Assimes, Themistocles L ⁱ   Bottinger, Erwin P ^j   Chambers, John C ^k,l,m   Clarke, Robert ^c   Palmer, Colin N A ⁿ   Cubbon, Richard M ^o   Ellinor, Patrick ^p   Ermel, Raili ^q   Evangelou, Evangelos ^k,r   Franks, Paul W ^s,t,u   Grace, Christopher ^c,d   Gu, Dongfeng ^v   Hingorani, Aroon D ^w   Howson, Joanna M M ^e   Ingelsson, Erik ⁱ   Kastrati, Adnan ^h   Kessler, Thorsten ^h   Kyriakou, Theodosios ^c,d   Lehtimäki, Terho ^x   Lu, Xiangfeng ⁱ   Lu, Yingchang ^j,y   März, Winfried ^z,aa,ab   McPherson, Ruth ^ac   Metspalu, Andres ^ad   Pujades Rodriguez, Mar ^ae   Ruusalepp, Arno ^q,af   Schadt, Eric E ^j   Schmidt, Amand F ^w   Sweeting, Michael J ^e   Zalloua, Pierre A ^t,ag   Alghalayini, Kamal ^ah   Keavney, Bernard D ^ai,aj   Kooner, Jaspal S ^l,m,ak   Loos, Ruth J F ^j   Patel, Riyaz S ^w,al   Rutter, Martin K ^ai,aj   Tomaszewski, Maciej ^aj   Tzoulaki, Ioanna ^k,r   Zeggini, Eleftheria ^am   Erdmann, Jeanette ^an,ao,ap   Dedoussis, George ^aq   Björkegren, Johan L M ^j,af,ar   Schunkert, Heribert ^h   Farrall, Martin ^c,d   Danesh, John ^e,as   Samani, Nilesh J ^a,b   Watkins, Hugh ^c,d   Deloukas, Panos ^f,g,ah   more..

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b National Institute for Health Research Leicester Biomedical Research Centre ^*  (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l EALING HOSPITAL   (United Kingdom)

^m IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

ⁿ UNIVERSITY OF DUNDEE   (United Kingdom)

^o UNIVERSITY OF LEEDS   (United Kingdom)

^p MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^q TARTU UNIVERSITY HOSPITAL   (Estonia)

^r UNIVERSITY OF IOANNINA   (Greece)

^s LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^t HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^u UMEÅ UNIVERSITY   (Sweden)

^v FUWAI HOSPITAL   (China)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

^x TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^y VANDERBILT INGRAM CANCER CENTER   (United States)

^z MEDICAL UNIVERSITY OF GRAZ   (Austria)

^aa UNIVERSITY OF HEIDELBERG   (Germany)

^ab SYNLAB ACADEMY   (Germany)

^ac UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^ad UNIVERSITY OF TARTU   (Estonia)

^ae UNIVERSITY OF LEEDS   (United Kingdom)

^af Clinical Gene Networks AB   (Sweden)

^ag LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^ah KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^ai UNIVERSITY OF MANCHESTER   (United Kingdom)

^aj MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^ak NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^al ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^am WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^an UNIVERSITY OF LÜBECK   (Germany)

^ao DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^ap University Heart Center Lübeck   (Germany)

^aq HAROKOPIO UNIVERSITY   (Greece)

^ar KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^as WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANGINA PECTORIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOBANK; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HERITABILITY; HUMAN; INFLAMMATION; LIPID METABOLISM; MONTE CARLO METHOD; MORPHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MEDICAL INFORMATION SYSTEM; META ANALYSIS (TOPIC); PROCEDURES; REPRODUCIBILITY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

CORONARY ARTERY DISEASE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEALTH INFORMATION SYSTEMS; HUMANS; META-ANALYSIS AS TOPIC; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UNITED KINGDOM;

EID: 85028693072     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3913     Document Type: Article

References (39)

1. CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013).
2. Nikpay, M. et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121-1130 (2015).
3. Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016).
4. Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Systematic evaluation of pleiotropy identifies six further loci associated with coronary artery disease. J. Am. Coll. Cardiol. 69, 823-836 (2017).
5. Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186-190 (2017).
6. Townsend, N., Bhatnagar, P., Wilkins, E., Wickramasinghe, K. & Rayner, M. Cardiovascular Disease Statistics 2015 (British Heart Foundation, 2015).
7. Yang, J., Ferreira, T., Morris, A.P. & Medland, S.E. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369-375 (2012).
8. Danesh, J. et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur. J. Epidemiol. 22, 129-141 (2007).
9. Wipff, P.J., Rifkin, D.B., Meister, J.J. & Hinz, B. Myofibroblast contraction activates latent TGF-α1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323 (2007).
10. Henderson, N.C. et al. Targeting of v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat. Med. 19, 1617-1624 (2013).
11. Goumans, M.J., Liu, Z. & ten Dijke, P. TGF-αsignaling in vascular biology and dysfunction. Cell Res. 19, 116-127 (2009).
12. Nanda, V. et al. CDKN2B regulates TGFαsignaling and smooth muscle cell investment of hypoxic neovessels. Circ. Res. 118, 230-240 (2016).
13. Franzén, O. et al. Cardiometabolic risk loci share downstream cis-and trans-gene regulation across tissues and diseases. Science 353, 827-830 (2016).
14. Kukreja, R.C., Salloum, F.N. & Das, A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J. Am. Coll. Cardiol. 59, 1921-1927 (2012).
15. The GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660 (2015).
16. Samson, T. et al. The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis. PLoS One 8, e55202 (2013).
17. Babaev, V.R. et al. Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 197, 534-540 (2008).
18. Rohwedder, I. et al. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol. Med. 4, 564-576 (2012).
19. Pers, T.H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
20. Fuchsberger, C. et al. The genetic architecture of type 2 diabetes. Nature 536, 41-47 (2016).
21. Surakka, I. et al. The impact of low-frequency and rare variants on lipid levels. Nat. Genet. 47, 589-597 (2015).
22. Howson, J.M.M. et al. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. Nat. Genet. 49, 1113-1119 (2017).
23. Pirinen, M., Donnelly, P. & Spencer, C.C. Including known covariates can reduce power to detect genetic effects in case-control studies. Nat. Genet. 44, 848-851 (2012).
24. Mägi, R. & Morris, A.P. GWAMA: software for genome-wide association metaanalysis. BMC Bioinformatics 11, 288 (2010).
25. Newson, R. QQVALUE: Stata module to generate quasi-q-values by inverting multipletest procedures S457100 (Boston College Department of Economics, 2013).
26. Bigdeli, T.B. et al. A simple yet accurate correction for winner's curse can predict signals discovered in much larger genome scans. Bioinformatics 32, 2598-2603 (2016).
27. Newson, R. Multiple-test procedures and smile plots. Stata J. 3, 109-132 (2003).
28. Witte, J.S., Visscher, P.M. & Wray, N.R. The contribution of genetic variants to disease depends on the ruler. Nat. Rev. Genet. 15, 765-776 (2014).
29. Muñoz, M. et al. Evaluating the contribution of genetics and familial shared environment to common disease using the UK Biobank. Nat. Genet. 48, 980-983 (2016).
30. Ward, L.D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
31. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
32. Skipper, M. et al. Presenting the Epigenome Roadmap. Nature 518, 313 (2015).
33. Matys, V. et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374-378 (2003).
34. Portales-Casamar, E. et al. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res. 38, D105-D110 (2010).
35. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
36. Ritchie, G.R., Dunham, I., Zeggini, E. & Flicek, P. Functional annotation of noncoding sequence variants. Nat. Methods 11, 294-296 (2014).
37. Boyle, A.P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
38. Staley, J.R. et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32, 3207-3209 (2016).
39. Fehrmann, R.S. et al. Gene expression analysis identifies global gene dosage sensitivity in cancer. Nat. Genet. 47, 115-125 (2015).